Skip to content

Study on changes in intestinal microflora and metabolites due to amazake consumption

Study on changes in intestinal microflora and metabolites due to amazake consumption - Study on changes in intestinal microflora and metabolites due to amazake consumption

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057511
Enrollment
45
Registered
2025-04-10
Start date
2025-04-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

A two-week consumption of amazake with added soy and inulin, adjusted for flavor. A two-week consumption of amazake with added germinated pressed barley and inulin, adjusted for flavor. A two-week con

Sponsors

CORAZON Corporation
Lead Sponsor
National Institutes of Biomedical Innovation, Health and Nutrition
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participants must be part of the study "Research on the Relationship Between Lifestyle Habits and Resident Microbiota" conducted by the Health Lab Station and the National Institutes of Biomedical Innovation, Health, and Nutrition. Participants must attend an explanatory session and express their willingness to participate in the study. Previously collected data from observational studies, including vitamin B1 intake, the proportion of butyrate-producing bacteria in stool, and the levels of butyrate and acetate in stool, must be available.

Exclusion criteria

Exclusion criteria: Individuals who regularly consume amazake, those with allergies to rice, wheat, or soy, and those deemed unsuitable as participants (e.g., individuals unable to properly collect samples, unable to provide health examination results and related information, or those who may have difficulty continuing the intervention, such as those with a history of adverse reactions to amazake consumption)

Design outcomes

Primary

MeasureTime frame
Changes in fecal metabolites and gut microbiota.

Secondary

MeasureTime frame
Fecal bioactive substances, immune factors, metabolic enzymes, microbial genes; general blood test parameters; blood bioactive substances, immune factors, metabolites, metabolic enzymes; body measurements, physical condition, and lifestyle habits.

Countries

Japan

Contacts

Public ContactYUKA KAWAMURA

CORAZON Corporation Branding Department

kawamura-y@corazon.jp090-4301-4139

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026